Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus under the brand name Mounjaro and for chronic weight management under the brand name Zepbound
However, like any medication combination, this approach should be carefully monitored by a healthcare provider to ensure its safe and effective
AOD 9604 has been evaluated in rodent models of obesity
If you qualify, youll have a telehealth consultation with a board-certified physician who will review your medical history and prescribe the medication, if medically appropriate
USA 112 , 1185211857 (2015)
Take progress photos Visual changes in your body can be more motivating than the scale
US$ 27.62
US$ 22.02
US$ 28.77
US$ 23.16
US$ 20.59
US$ 26.57
US$ 24.16
